Search for: "AMGEN INC." Results 281 - 300 of 704
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 May 2016, 1:42 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
11 Apr 2016, 2:38 am
Advocate General delivers opinion in United Video Properties, Inc v Telenet NV, C-57/15. [read post]
2 Apr 2016, 4:00 am by Steve Brachmann
The post Injectable migraine treatment being developed by Alder, Eli Lilly, Amgen and others appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
17 Mar 2016, 2:45 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
12 Mar 2016, 12:48 pm by Lawrence B. Ebert
Although Tecfidera's pill form does improve patient compliance, Roche has a injectable multiple sclerosis candidate, ocrelizumab, that could slow Tecfidera's growth even further, as it might only require administration once every six months. link: http://www.fool.com/investing/general/2016/03/10/better-buy-amgen-inc-vs-biogen.aspxAs to administration, Tecfidera (whose chemical identity is simply methyl esters of fumaric acid) is oral, while ocrelizumab is a monoclonal… [read post]
4 Mar 2016, 12:25 pm by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
’”Greenliant, 692 F.3d at 1268 (quoting Amgen, 580 F.3d at1340). [read post]
25 Jan 2016, 1:31 pm by Lyle Denniston
  In the second summary ruling, in Amgen Inc., v. [read post]
22 Jan 2016, 8:12 am by John Elwood
Brown, 14-10186 (a Jewish prisoner denied permission to meet and pray with others because prison officials believed there were an insufficient number of people for organized prayer under their understanding of Judaism); Ben-Levi is joined by two-time relists Amgen Inc. v. [read post]
26 Nov 2015, 8:12 am
 Per the precedent set in Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46 (and other cases since), the question is "...what the person skilled in the art would have understood the Patentee to be using the language of the claim to mean". [read post]